Effects of Carnosine, Aminoguanidine, and Aspirin on Cataracts in Diabetic Rats
Author Information
Author(s): Yan Hong, Guo Yong, Zhang Jie, Ding Zhenghua, Ha Wenjing, Harding J.J.
Primary Institution: Tangdu Hospital, Fourth Military Medical University, Xi’an, China
Hypothesis
The study investigates the effect of carnosine, aminoguanidine, and aspirin drops on the development of diabetic cataracts in rats.
Conclusion
Carnosine treatment delayed cataract progression in diabetic rats, while aminoguanidine and aspirin had less significant effects.
Supporting Evidence
- Carnosine treatment delayed cataract progression significantly at four weeks.
- Aminoguanidine and aspirin did not show significant effects on cataract progression.
- The untreated diabetic rats had a higher level of glycated lens protein compared to normal rats.
Takeaway
This study tested three eye drops to see if they could help prevent cataracts in diabetic rats, and found that one of them, carnosine, worked better than the others.
Methodology
Diabetic rats were treated with carnosine, aminoguanidine, and aspirin drops, and lens opacification was monitored over 13 weeks.
Limitations
The study was limited by the number of surviving rats in some treatment groups, which may affect the reliability of the results.
Participant Demographics
Sprague-Dawley male rats were used in the study.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website